الصفحة الرئيسية>>Natural Products>>(-)-11-nor-9-carboxy-δ9-THC-d3 (exempt preparation)

(-)-11-nor-9-carboxy-δ9-THC-d3 (exempt preparation) (Synonyms: (-)-11-nor-9-carboxy-Δ9-Tetrahydrocannabinol-d3)

رقم الكتالوجGC48705

An Analytical Reference Standard

Products are for research use only. Not for human use. We do not sell to patients.

(-)-11-nor-9-carboxy-δ9-THC-d3 (exempt preparation) التركيب الكيميائي

Cas No.: 130381-15-6

الحجم السعر المخزون الكميّة
100µg
83٫00
متوفر
500µg
378٫00
متوفر
1mg
672٫00
متوفر

Tel:(909) 407-4943 Email: sales@glpbio.com

مراجعات العميل

بناء على آراء العملاء.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents

(-)-11-nor-9-carboxy-δ9-THC-d3 (exempt preparation) contains three deuterium atoms at the 5 position. It is intended for use as an internal standard for the quantification of (-)-11-nor-9-carboxy-δ9-THC (exempt preparation) by GC- or LC-mass spectrometry. δ9-Tetrahydrocannabinol (δ9-THC), the active constituent of marijuana, is metabolized primarily by hydroxylation at the allylic C-11 position followed by oxidation to (-)-11-nor-9-carboxy-δ9-THC. (-)-11-nor-9-carboxy-δ9-THC is the major metabolite of δ9-THC and is used as an internal standard in various analytical procedures to unequivocally confirm its presence in biological fluids.1

1.Siegel, C., Gordon, P.M., Uliss, D.B., et al.Synthesis of racemic and optically active δ9-tetrahydrocannabinol (THC) metabolitesThe Journal of Organic Chemistry56(24)6865-6872(1991)

مراجعات

Review for (-)-11-nor-9-carboxy-δ9-THC-d3 (exempt preparation)

Average Rating: 5 ★★★★★ (Based on Reviews and 34 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for (-)-11-nor-9-carboxy-δ9-THC-d3 (exempt preparation)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.